For thousands living with spinal muscular atrophy who aged out of early approvals, the FDA’s greenlight of an intrathecal gene therapy redrew the treatment map and challenged long‑held limits. The authorization of Itvisma, an intrathecal formulation of onasemnogene abeparvovec for patients two
In a world where patients often wait nearly a year for life-saving drugs to gain approval, a groundbreaking initiative by the FDA is slashing that timeline to mere weeks, promising a dramatic shift in biopharma. The Commissioner’s National Priority Voucher (CNPV) pilot program is not just speeding
The landscape of oncology treatment is witnessing a transformative shift with Johnson & Johnson (J&J) securing a positive recommendation from the UK’s National Institute for Health and Care Excellence (NICE) for its groundbreaking therapy, TALVEY (talquetamab). This approval for use within the
Multiple myeloma, a challenging blood cancer, affects thousands of individuals annually, often progressing from a precursor condition known as high-risk smoldering multiple myeloma (HR-SMM). With around 50% of HR-SMM cases advancing to active disease within just a couple of years, the stakes are
In the shadow of an unrelenting conflict in Gaza that intensified after the devastating events of October 7, 2023, a deeply troubling humanitarian crisis has unfolded, capturing the attention of human rights advocates worldwide. Dozens of Palestinian medical workers, vital to a region already
Across the globe, mental disorders stand as a formidable public health challenge, contributing to significant disability, premature mortality, and crushing economic burdens on both patients and healthcare systems. In China, where the lifetime prevalence of these conditions exceeds 16%, the
